Related Experiment Video
Updated: Sep 29, 2025

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
Published on: November 30, 2022
Application of Deep Learning in Breast Cancer Imaging
Luuk Balkenende1, Jonas Teuwen2, Ritse M Mann1
1Department of Radiology, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Deep learning (DL) shows promise in breast cancer imaging, matching or exceeding radiologist performance in tasks like lesion detection and risk prediction. Further large trials are needed to confirm its clinical value, especially for ultrasound and MRI, alongside addressing ethical considerations.
Area of Science:
- Radiology
- Artificial Intelligence
- Medical Imaging
Background:
- Breast imaging is crucial for early cancer detection, treatment monitoring, and response assessment.
- Digitalization of imaging modalities like mammography, ultrasound, and MRI enables AI integration.
- Deep learning (DL) is a rapidly advancing subset of AI with significant potential in medical diagnostics.
Purpose of the Study:
- To provide a comprehensive overview of current deep learning research in breast cancer imaging.
- To highlight the applications of DL across various breast imaging techniques and diagnostic tasks.
- To identify the current limitations and future directions for DL in clinical breast care.
Main Methods:
- Review of existing literature on deep learning applications in breast cancer imaging.
- Analysis of DL performance in tasks including lesion classification, segmentation, image reconstruction, and risk prediction.
- Evaluation of DL's role in different imaging modalities: mammography, digital breast tomosynthesis, ultrasound, MRI, and nuclear medicine.
Main Results:
- Deep learning algorithms demonstrate comparable or superior performance to radiologists in several breast imaging tasks.
- DL is applied to lesion classification, segmentation, image generation, risk prediction, and therapy response assessment.
- Research on DL in nuclear medicine imaging is limited, requiring further investigation.
Conclusions:
- Deep learning holds significant potential to enhance breast cancer detection and management.
- Large-scale clinical trials are essential to validate DL's added value, particularly in ultrasound and MRI.
- Addressing legal, ethical, and regulatory aspects is critical for the widespread adoption of DL in breast imaging practice.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020